DioGenix
Bethesda, Maryland, United States
About DioGenix
DioGenix, Inc. engages in the discovery, development, and commercialization of non-invasive diagnostic, prognostic, and treatment response monitoring tests. Its lead program is designed to provide neurologists with a set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types, and predict response to treatment using non-invasive blood tests. The company was incorporated in 2007 and is based in Gaithersburg, Maryland. As of September 19, 2008, DioGenix, Inc. operates as a subsidiary of Nerveda, Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.2M
- Funding stage: M&A
- Last round: Seed (Dec 2013)
- Website: diogenix.com
- Phone: +1 858-245-8489
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/diogenix-2608370 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.